Story perspectives

Pentagon rescinds testosterone screening guidance for troops 30+

9/4/2026

Center

Pentagon Drops Testosterone Screening

The Pentagon rescinded a clinical guidance mandating testosterone deficiency screening for active-duty and reserve service members aged 30 and older.
Officials said the rescission was to allow updates while interim screening guidance remains in effect.
The Endocrine Society said evidence is insufficient for population screening and that widespread testing may cause treatment.
The guidance, posted on September 2, 2026, was removed the day after Pentagon spokesperson Sean Parnell released a statement.

Left

Pentagon Halts Screening

The Pentagon withdrew a draft guidance that would have required testosterone deficiency screening for active-duty/reserve members aged 30 and older.
Guidance was presented as Defense Secretary Pete Hegseth’s effort to reshape military into a male image for President Donald Trump.
The draft required testosterone tests for men 30+ and optional testing for younger men.
It instructed women members over 35 to report hormonal symptoms and be referred for assessment.

Blindspot

Defense Secretary Pete Hegseth presented the draft guidance as part of a drive to reshape the force toward a male-focused, “fit” image aligned with President Donald Trump’s agenda, and it instructed women service members over 35 to be asked about hormonal symptoms.
Within this story's sources, this angle appears mainly in Left-leaning coverage and receives less attention in Center-leaning coverage.

History

Historical Context

In 1994, the Department of Defense issued Instruction 6130.03, revising medical standards to include gender-specific screening criteria for service members. At that time, women accounted for 13 percent of the 1.1 million active-duty force, roughly 140,000 service members, prompting the DoD and U.S. Army to codify separate health assessments. The 2026 temporary rescindment of mandatory testosterone-deficiency screening mirrors the 1994 gender-specific standards, both creating distinct medical pathways for male and female soldiers. Repeated reliance on gender-differentiated health policies may compel Congress and the Pentagon to pursue unified medical guidelines, reducing inequities and legal challenges.

1 of 4

Pentagon Drops Testosterone Screening

The Pentagon rescinded a clinical guidance mandating testosterone deficiency screening for active-duty and reserve service members aged 30 and older.
Officials said the rescission was to allow updates while interim screening guidance remains in effect.
The Endocrine Society said evidence is insufficient for population screening and that widespread testing may cause treatment.
The guidance, posted on September 2, 2026, was removed the day after Pentagon spokesperson Sean Parnell released a statement.

1 / 4